More Beijing Beilu Pharmaceutical Co., Ltd. Class A news
Beijing Beilu Pharmaceutical Co., Ltd. Class ASZSE: 300016

Beijing Beilu Says Bimatoprost Ophthalmic Solution Receives Drug Registration Certificate

Sep 20, 2026 at 8:41 AM UTC · Issued by Beijing Beilu Pharmaceutical Co., Ltd. Class A

Beijing Beilu Pharmaceutical Co Ltd SZSE:300016:

  • SAYS BIMATOPROST OPHTHALMIC SOLUTION RECEIVES NMPA'S DRUG REGISTRATION CERTIFICATE